Average Co-Inventor Count = 6.07
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (30 from 291 patents)
30 patents:
1. 9242974 - Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives
2. 8962551 - Quinoxalinyl derivatives
3. 8927739 - Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives
4. 8921573 - Processes for the preparation of novel benzimidazole derivatives
5. 8809264 - Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors
6. 8778938 - Hepatitis C virus inhibitors
7. 8609648 - Hepatitis C virus inhibitors
8. 8552162 - Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
9. 8501681 - Macrocyclic hepatitis C virus serine protease inhibitors
10. 8426458 - Hepatitis C Virus inhibitors
11. 8420686 - Linked diimidazole antivirals
12. 8236807 - Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
13. 8124584 - Macrocyclic hepatitis C serine protease inhibitors
14. RE42375 - Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
15. 7919627 - Processes for the preparation of hydroxylamines